Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FFCQ2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,780
Award facts
- Contract value 100% obligated
- $15,779.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for AIMOVIG 140 mg/ml auto-injector units. This firm fixed-price delivery order, valued at $15,779.75, was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. The award represents a non-set-aside, competitively awarded contract supporting federal medical procurement needs. This delivery order is issued under AmerSourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AIMOVIG is a migraine treatment medication administered via auto-injector, and this delivery order fulfills immediate pharmaceutical supply requirements for the Defense Health Agency and other federal healthcare systems. As a child contract under the larger DLA Troop Support Medical IDC, this award reflects AmerSourceBergen Drug Corp's established capability to meet federal procurement requirements through open competition and its critical role in supporting military and veteran healthcare supply chains. The rapid completion timeline indicates this represents an urgent medical supply need within the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FFCQ2?
SPE2DB25FFCQ2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FFCQ2 worth?
The government has obligated $15,780 on SPE2DB25FFCQ2.
Is contract SPE2DB25FFCQ2 an order under another contract?
Yes. SPE2DB25FFCQ2 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFCQ2 competed?
The extent of competition for SPE2DB25FFCQ2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award